Karenitecin in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer or Primary Peritoneal Cancer
Conditions
- Primary Peritoneal Carcinoma
- Recurrent Ovarian Carcinoma
Interventions
- DRUG: Cositecan
- OTHER: Pharmacological Study
Sponsor
Gynecologic Oncology Group
Collaborators